Roberts R E, Kendall D A, Wilson V G
School of Biomedical Sciences, Medical School, University of Nottingham, Queen's Medical Centre.
Br J Pharmacol. 1999 May;127(1):284-90. doi: 10.1038/sj.bjp.0702544.
Enhanced contractions of the porcine isolated ear artery by the alpha2-adrenoceptor agonist UK14304 are uncovered by pharmacological manipulation. As both neuropeptide Y (NPY) receptors and alpha2-adrenoceptors are negatively-coupled to adenylyl cyclase in this tissue, we determined whether NPY is also able to produce an enhanced contraction in the same tissue, under the same conditions. NPY (0.1 microM) produced a small contraction of porcine isolated ear arteries which was 5.1+/-0.8% of the response to 60 mM KCl (n = 14). An enhanced NPY response was uncovered if the tissue was pre-contracted with 0.1 microM U46619, and relaxed back to baseline with 1-2 microM forskolin before the addition of NPY (49.8+/-5.3%, n = 14). Forskolin (1 microM) stimulated cyclic AMP accumulation in porcine ear artery segments in the presence of 0.1 microM U46619 and 1 mM isobutylmethylxanthine (IBMX), NPY (0.1 microM) inhibited this response by 40%, but had no effect on basal levels of cyclic AMP. An enhanced response to 0.1 microM NPY was also obtained after pre-contraction with 0.1 microM U46619 and relaxation with either SNP (28.9+/-5.7%, n = 14), or dibutyryl cyclic AMP (21.2+/-4.6%, n = 14). This indicates that at least part of the enhanced response to NPY is independent of the agonist's ability to inhibit adenylyl cyclase. In conclusion, an enhanced contraction to NPY in the porcine isolated ear artery can be obtained by prior pharmacological manipulation. The enhanced responses are mediated through adenylyl cyclase-dependent and independent pathways similar to those reported for alpha2-adrenoceptors in this preparation.
通过药理学操作发现,α2 - 肾上腺素能受体激动剂UK14304可增强猪离体耳动脉的收缩。由于该组织中神经肽Y(NPY)受体和α2 - 肾上腺素能受体均与腺苷酸环化酶负偶联,我们确定了NPY在相同条件下是否也能在同一组织中产生增强的收缩。NPY(0.1微摩尔)使猪离体耳动脉产生轻微收缩,收缩幅度为对60毫摩尔氯化钾反应的5.1±0.8%(n = 14)。如果在加入NPY之前,先用0.1微摩尔U46619预收缩组织,再用1 - 2微摩尔福斯高林使其松弛至基线水平,则可发现NPY反应增强(49.8±5.3%,n = 14)。在存在0.1微摩尔U46619和1毫摩尔异丁基甲基黄嘌呤(IBMX)的情况下,福斯高林(1微摩尔)刺激猪耳动脉段中的环磷酸腺苷(cAMP)积累,NPY(0.1微摩尔)使该反应抑制40%,但对cAMP的基础水平无影响。在用0.1微摩尔U46619预收缩并分别用硝普钠(SNP,28.9±5.7%,n = 14)或二丁酰环磷酸腺苷(21.2±4.6%,n = 14)松弛后,对0.1微摩尔NPY的反应也增强。这表明对NPY增强反应的至少一部分与激动剂抑制腺苷酸环化酶的能力无关。总之,通过事先的药理学操作可使猪离体耳动脉对NPY的收缩增强。增强反应是通过与该制剂中α2 - 肾上腺素能受体报道的类似的腺苷酸环化酶依赖性和非依赖性途径介导。